Acme United(ACU)
Search documents
Acme United(ACU) - 2022 Q4 - Annual Report
2023-03-09 16:00
```markdown [Part I](index=3&type=section&id=Part%20I) [Business](index=3&type=section&id=Item%201.%20Business) Acme United is a global supplier of first aid, medical, and cutting products, achieving record $194 million net sales in 2022 [Overview](index=3&type=section&id=Overview) - Acme United is a leading supplier of first aid, medical, and cutting technology products for various markets, with total net sales of **$194 million** in 2022[3](index=3&type=chunk) - The company has achieved **thirteen consecutive years of record annual sales growth**, averaging **10%** per year[3](index=3&type=chunk) - First aid and medical products have grown to represent approximately **55% of total sales**, reducing reliance on school and office products[3](index=3&type=chunk) - In 2022, the company acquired Safety Made, a first aid promotional business, and increased its revolving loan facility from **$50 million to $65 million**[3](index=3&type=chunk) - Cost reduction initiatives implemented in the second half of 2022 are expected to generate over **$5 million in savings** in 2023[3](index=3&type=chunk) [Principal Products](index=3&type=section&id=Principal%20Products) - The company's products are categorized into two main groups: 'first aid and medical' and 'cutting, sharpening and measuring'[4](index=4&type=chunk) - The 'first aid and medical' category includes brands such as First Aid Only®, PhysiciansCare®, Pac-Kit®, Spill Magic®, First Aid Central®, Med-Nap, and Safety Made[4](index=4&type=chunk)[5](index=5&type=chunk) - The 'cutting, sharpening and measuring' category includes brands like Westcott®, Clauss®, Camillus®, Cuda®, and DMT® for various markets including school, home, office, hardware, and sporting goods[4](index=4&type=chunk)[5](index=5&type=chunk)[6](index=6&type=chunk) [Intellectual Property](index=5&type=section&id=Intellectual%20Property) - The company holds numerous patents and trademarks crucial to its business, including Westcott, Clauss, Camillus, PhysiciansCare, First Aid Only, Cuda, DMT, Pac-Kit, Spill Magic, and First Aid Central[9](index=9&type=chunk) - The weighted average amortization period remaining for intangible assets as of December 31, 2022, was **9 years**[9](index=9&type=chunk) [Product Distribution; Major Customers](index=5&type=section&id=Product%20Distribution%3B%20Major%20Customers) - Products are sold through independent manufacturer representatives and direct sales to a variety of channels, including mass market, e-commerce, and industrial distributors[10](index=10&type=chunk) Major Customer Sales Concentration | Year | Customer 1 (% of Net Sales) | Customer 2 (% of Net Sales) | | :--- | :--- | :--- | | 2022 | 15% | 10% | | 2021 | 17% | 11% | [Competition](index=6&type=section&id=Competition) - The company faces competition based on product innovation, quality, price, and design[11](index=11&type=chunk) - Major competitors in the cutting category are 3M and Fiskars Corporation[11](index=11&type=chunk) - Major competitors in the first aid and safety category are Honeywell and Cintas[11](index=11&type=chunk) [Seasonality](index=6&type=section&id=Seasonality) - Sales and profits are typically stronger in the second and third quarters due to the seasonal nature of the Westcott back-to-school market[12](index=12&type=chunk) [Employees and Human Capital Considerations](index=6&type=section&id=Employees%20and%20Human%20Capital%20Considerations) - As of December 31, 2022, the company employed **619 full-time people**, none of whom are covered by union contracts[14](index=14&type=chunk) - The company is committed to a diverse workforce and provides market-competitive pay and benefits, including medical, dental, vision, 401(k), and flexible spending accounts[15](index=15&type=chunk) [Risk Factors](index=6&type=section&id=Item%201A.%20Risk%20Factors) The company faces operational, legal, regulatory, and market risks, including supply chain, IP, and geopolitical factors [Industry and Operational Risks](index=6&type=section&id=Industry%20and%20Operational%20Risks) - The company expects to continue experiencing inflationary pressure on its cost structure, and price increases may not fully offset these costs or could lead to lower sales volumes[20](index=20&type=chunk) - Supply chain issues, including vendor delays and shipping difficulties, can impact timely product delivery and may result in contractual penalties[22](index=22&type=chunk) - The loss of a major customer could significantly decrease sales and earnings, as two customers accounted for approximately **15% and 10%** of consolidated net sales in 2022[28](index=28&type=chunk) - The e-commerce business, which constituted about **17%** of net sales in 2022, faces risks related to demand forecasting and reliance on third-party platforms[31](index=31&type=chunk) - The company has substantial indebtedness, with **$50 million** outstanding under its revolving credit facility and over **$11 million** on a mortgage as of year-end 2022, which could affect financial flexibility[35](index=35&type=chunk) [Legal and Regulatory Risks](index=11&type=section&id=Legal%20and%20Regulatory%20Risks) - The company's success is partly dependent on its ability to obtain and protect patents, trademarks, and other intellectual property rights[38](index=38&type=chunk) - Product liability claims or regulatory actions could lead to monetary judgments, negative publicity, and costly recalls, potentially harming the company's reputation and financial results[39](index=39&type=chunk) - Certain products and facilities are subject to regulation by the FDA and analogous foreign regulators, and failure to comply could lead to facility shutdowns or product recalls[41](index=41&type=chunk) - The company is subject to various environmental laws and regulations, and the costs of compliance or liability for contamination could have a material adverse effect[42](index=42&type=chunk) [Risks Related to Our Overseas Operations](index=12&type=section&id=Risks%20Related%20to%20Our%20Overseas%20Operations) - Global operations expose the company to risks from political, regulatory, and economic conditions in foreign countries, as well as currency exchange rate fluctuations[43](index=43&type=chunk)[44](index=44&type=chunk) - The company relies on foreign suppliers, primarily in China, subjecting it to risks such as regulatory changes, political instability, and the impact of pandemics on the supply chain[45](index=45&type=chunk) - Changes in U.S. trade policies, including the imposition of tariffs on products from China, may negatively impact customer demand and financial results[47](index=47&type=chunk) [Risks Related to Our Common Stock](index=13&type=section&id=Risks%20Related%20to%20Our%20Common%20Stock) - There is no assurance that the company will continue to pay dividends or repurchase shares under its stock repurchase program[48](index=48&type=chunk)[49](index=49&type=chunk) - The company's common stock is thinly traded, which can lead to greater price volatility compared to the broader market[49](index=49&type=chunk) [Properties](index=14&type=section&id=Item%202.%20Properties) The company owns 481,460 sq ft and leases 197,600 sq ft for operations across various locations Owned and Leased Properties | Status | Total Square Footage | Primary Use | | :--- | :--- | :--- | | Owned | 481,460 | Warehousing, manufacturing, distribution, administrative | | Leased | 197,600 | Administrative, manufacturing, warehousing, distribution | [Legal Proceedings](index=14&type=section&id=Item%203.%20Legal%20Proceedings) No pending material legal proceedings exist, nor is the company aware of any contemplated by governmental agencies - There are no pending material legal proceedings to which the Company is a party[49](index=49&type=chunk) [Part II](index=15&type=section&id=Part%20II) [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=15&type=section&id=Item%205.%20Market%20for%20Registrant%27s%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) Common stock trades on NYSE American; no repurchases in 2022, 160,365 shares remain available - The Company's Common Stock is traded on the NYSE American under the symbol 'ACU'[50](index=50&type=chunk) - The company did not repurchase any shares of its Common Stock during 2022. As of December 31, 2022, **160,365 shares** may still be purchased under the 2019 repurchase program[51](index=51&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=16&type=section&id=Item%207.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Net sales grew 7% to $194.0 million in 2022, but gross margin declined due to high costs, impacting net income [Results of Operations 2022 Compared with 2021](index=17&type=section&id=Results%20of%20Operations%202022%20Compared%20with%202021) Financial Performance Comparison (2022 vs. 2021) | Metric | 2022 | 2021 | Change | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Net Sales | $194.0M | $182.1M | +$11.9M | +7% | | Gross Profit | $63.6M | $64.8M | -$1.2M | -1.8% | | Gross Margin | 32.8% | 35.6% | -2.8 pts | N/A | | Operating Income | $6.3M | $12.8M | -$6.5M | -50.9% | | Net Income | $3.0M | $13.7M | -$10.7M | -78.4% | - The decline in gross profit margin was primarily due to exceptionally high ocean container costs and demurrage charges, which had a **1.7% negative impact**[59](index=59&type=chunk) - SG&A expenses increased by **10.1%** to **$57.3 million**, driven by higher personnel costs, commissions, and shipping costs, including fuel surcharges[59](index=59&type=chunk) - Net interest expense more than doubled to **$2.4 million** from **$0.9 million** in 2021, due to higher average interest rates and higher average debt outstanding[60](index=60&type=chunk) [Liquidity and Capital Resources](index=19&type=section&id=Liquidity%20and%20Capital%20Resources) - Working capital increased by approximately **$8.5 million** in 2022, primarily due to an **$9.7 million (18%)** increase in inventory to offset potential supply chain disruptions[63](index=63&type=chunk) - The company amended its revolving loan agreement, increasing the borrowing availability from **$50 million to $65 million** and extending the expiration to May 2026[63](index=63&type=chunk) - As of December 31, 2022, **$50 million** was outstanding under the revolving credit facility, with **$15 million** available for borrowing[63](index=63&type=chunk) - On June 1, 2022, the company acquired Safety Made for approximately **$11 million**, including **$1.5 million** in contingent payments[63](index=63&type=chunk) [Financial Statements and Supplementary Data](index=20&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) 2022 financial statements show $194.0 million net sales, $3.0 million net income, and increased assets, with unqualified audit opinion [Consolidated Statements of Operations](index=21&type=section&id=Consolidated%20Statements%20of%20Operations) Consolidated Statements of Operations Highlights (Year ended Dec 31) | Account | 2022 | 2021 | | :--- | :--- | :--- | | Net sales | $193,962,357 | $182,087,559 | | Gross profit | $63,558,785 | $64,800,357 | | Operating income | $6,273,302 | $12,769,987 | | Net income | $3,034,766 | $13,655,679 | | Diluted EPS | $0.82 | $3.45 | [Consolidated Balance Sheets](index=23&type=section&id=Consolidated%20Balance%20Sheets) Consolidated Balance Sheet Highlights (As of Dec 31) | Account | 2022 | 2021 | | :--- | :--- | :--- | | Total Current Assets | $105,600,013 | $95,250,614 | | Total Assets | $164,377,104 | $144,438,684 | | Total Current Liabilities | $22,126,662 | $20,275,112 | | Total Liabilities | $85,346,972 | $67,356,723 | | Total Stockholders' Equity | $79,030,132 | $77,081,961 | [Consolidated Statements of Cash Flows](index=25&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) Consolidated Statement of Cash Flows Highlights (Year ended Dec 31) | Activity | 2022 | 2021 | | :--- | :--- | :--- | | Net cash provided by operating activities | $2,891,739 | $5,140,578 | | Net cash used by investing activities | ($14,226,655) | ($6,372,615) | | Net cash provided by financing activities | $14,276,667 | $2,042,646 | | Net increase in cash and cash equivalents | $2,757,060 | $675,973 | [Notes to Consolidated Financial Statements](index=26&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) - The company's operations consist of three reportable geographic segments: United States (including Asia), Canada, and Europe[75](index=75&type=chunk) - The acquisition of Safety Made on June 1, 2022, for approximately **$11 million** resulted in the recording of **$3.4 million** in goodwill and **$5.1 million** in other intangible assets[112](index=112&type=chunk) - The company's revolving loan agreement was amended to increase borrowing capacity to **$65 million** and extend the maturity to **May 2026**. As of year-end, **$50 million** was outstanding[88](index=88&type=chunk) - In 2021, the company recorded **$3.5 million** in income from the forgiveness of its Paycheck Protection Program (PPP) loan[90](index=90&type=chunk) [Controls and Procedures](index=41&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded disclosure controls and internal control over financial reporting were effective as of December 31, 2022 - Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of December 31, 2022[128](index=128&type=chunk) - Management concluded that the company's internal control over financial reporting was effective as of December 31, 2022, based on the COSO framework[129](index=129&type=chunk) - The independent registered public accounting firm, Marcum LLP, issued an unqualified opinion on the effectiveness of the company's internal control over financial reporting[129](index=129&type=chunk) [Part III](index=42&type=section&id=Part%20III) [Directors, Executive Officers and Corporate Governance](index=42&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20and%20Corporate%20Governance) Information on directors, executive officers, and governance is incorporated by reference from the 2023 Proxy Statement - Detailed information is incorporated by reference from the Company's 2023 Proxy Statement[131](index=131&type=chunk) [Executive Compensation](index=42&type=section&id=Item%2011.%20Executive%20Compensation) Executive compensation information is incorporated by reference from the 2023 Proxy Statement - Detailed information is incorporated by reference from the Company's 2023 Proxy Statement[132](index=132&type=chunk) [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](index=42&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owners%20and%20Management%20and%20Related%20Stockholder%20Matters) Security ownership information is incorporated by reference from the 2023 Proxy Statement - Detailed information is incorporated by reference from the Company's 2023 Proxy Statement[132](index=132&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=42&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) Related transactions and director independence details are incorporated by reference from the 2023 Proxy Statement - Detailed information is incorporated by reference from the Company's 2023 Proxy Statement[132](index=132&type=chunk) [Principal Accounting Fees and Services](index=42&type=section&id=Item%2014.%20Principal%20Accounting%20Fees%20and%20Services) Principal accounting fees and services information is incorporated by reference from the 2023 Proxy Statement - Detailed information is incorporated by reference from the Company's 2023 Proxy Statement[133](index=133&type=chunk) [Part IV](index=43&type=section&id=Part%20IV) [Exhibits and Financial Statement Schedules](index=43&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section lists financial statements, schedules, and exhibits filed with or incorporated by reference into the Form 10-K - This section lists all financial statements, schedules, and exhibits filed with or incorporated by reference into the Form 10-K[134](index=134&type=chunk)[135](index=135&type=chunk) ```
Acme United(ACU) - 2022 Q4 - Earnings Call Transcript
2023-03-02 17:55
Acme United Corporation (NYSE:ACU) Q4 2022 Earnings Conference Call March 2, 2023 12:00 PM ET Company Participants Walter Johnsen - Chairman & Chief Executive Officer Paul Driscoll - Chief Financial Officer Conference Call Participants Jim Marrone - Singular Research Richard Dearnley - Longport Partners Peter Sidoti - Sidoti & Company Operator Good day and welcome to the Acme United Fourth Quarter 2022 Conference Call. At this time, I'd like to turn the call over to Walter Johnsen, Chairman and CEO. Please, ...
Acme United(ACU) - 2022 Q1 - Quarterly Report
2022-05-08 16:00
Part I — FINANCIAL INFORMATION [Item 1: Financial Statements (Unaudited)](index=3&type=section&id=Item%201%3A%20Financial%20Statements%20(Unaudited)) This section presents the company's unaudited condensed consolidated financial statements for the reporting period [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Details the company's assets, liabilities, and stockholders' equity at the end of the reporting period ASSETS (in thousands) | ASSETS | March 31, 2022 (unaudited) | December 31, 2021 (Note 1) | | :--- | :--- | :--- | | Cash and cash equivalents | $5,307 | $4,843 | | Accounts receivable, net | 34,605 | 34,221 | | Inventories | 60,716 | 53,552 | | Total current assets | 104,438 | 95,251 | | Net property, plant and equipment | 23,887 | 24,027 | | Goodwill | 4,800 | 4,800 | | Intangible assets, net | 16,888 | 17,231 | | Total assets | $153,077 | $144,439 | LIABILITIES & EQUITY (in thousands) | LIABILITIES & EQUITY | March 31, 2022 (unaudited) | December 31, 2021 (Note 1) | | :--- | :--- | :--- | | Accounts payable | $10,939 | $8,977 | | Other accrued liabilities | 8,937 | 9,909 | | Total current liabilities | 21,377 | 20,275 | | Long-term debt | 40,151 | 33,037 | | Total liabilities | 75,304 | 67,357 | | Total stockholders' equity | 77,773 | 77,082 | | Total liabilities and stockholders' equity | $153,077 | $144,439 | [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Summarizes revenues, costs, and expenses to report the company's net income over the period Metric (in thousands, except per share) | Metric | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | Net sales | $43,333 | $43,525 | | Cost of goods sold | 28,365 | 27,938 | | Gross profit | 14,968 | 15,587 | | Selling, general and administrative expenses | 13,597 | 12,619 | | Operating income | 1,371 | 2,968 | | Interest expense, net | 305 | 221 | | Income before income tax expense | 1,068 | 2,670 | | Income tax expense | 238 | 624 | | Net income | $830 | $2,046 | | Basic earnings per share | $0.24 | $0.61 | | Diluted earnings per share | $0.22 | $0.52 | | Dividends declared per share | $0.13 | $0.13 | [Condensed Consolidated Statements of Comprehensive Income](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) Reports net income and other comprehensive income, including foreign currency translation adjustments Metric (in thousands) | Metric | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | Net income | $830 | $2,046 | | Foreign currency translation adjustment | 27 | (188) | | Comprehensive income | $857 | $1,858 | [Condensed Consolidated Statement of Changes in Stockholders' Equity](index=7&type=section&id=Condensed%20Consolidated%20Statement%20of%20Changes%20in%20Stockholders'%20Equity) Details the changes in the company's equity accounts during the first quarter of 2022 Stockholders' Equity (in thousands) | Stockholders' Equity | Balances, Dec 31, 2021 | Net Income | Other Comprehensive Loss | Stock Compensation Expense | Distributions to Shareholders | Cash Settlement of Stock Options | Balances, Mar 31, 2022 | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Common Stock | $12,655 | - | - | - | - | - | $12,655 | | Treasury Stock | $(15,996) | - | - | - | - | - | $(15,996) | | Additional Paid-In Capital | $11,930 | - | - | 400 | - | (108) | $12,222 | | Accumulated Other Comprehensive Loss | $(1,380) | - | 27 | - | - | - | $(1,353) | | Retained Earnings | $69,873 | 830 | - | - | (458) | - | $70,245 | | Total | $77,082 | 830 | 27 | 400 | (458) | (108) | $77,773 | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Summarizes cash inflows and outflows from operating, investing, and financing activities Cash Flow Activity (in thousands) | Cash Flow Activity | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | Net cash used in operating activities | $(5,479) | $(336) | | Net cash used in investing activities | $(518) | $(1,480) | | Net cash provided by financing activities | 6,450 | 1,538 | | Effect of exchange rate changes on cash and cash equivalents | 11 | (32) | | Net change in cash and cash equivalents | 464 | (310) | | Cash and cash equivalents at beginning of period | 4,843 | 4,167 | | Cash and cash equivalents at end of period | $5,307 | $3,857 | [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Provides supplementary details on accounting policies and specific financial statement items [1. Basis of Presentation](index=9&type=section&id=1.%20Basis%20of%20Presentation) The financial statements are unaudited and should be read with the 2021 Annual Report on Form 10-K - The accompanying condensed consolidated financial statements are unaudited and include all necessary normal, recurring adjustments[28](index=28&type=chunk) - The financial statements do not include all disclosures normally required by GAAP and should be read in conjunction with the Company's 2021 Annual Report on Form 10-K[28](index=28&type=chunk) - The Company evaluated events and transactions subsequent to **March 31, 2022**, through the issuance date of these financial statements[29](index=29&type=chunk) [2. Commitment and Contingencies](index=9&type=section&id=2.%20Commitment%20and%20Contingencies) There are no pending material legal proceedings involving the Company or contemplated by governmental authorities - There are **no pending material legal proceedings** to which the Company is a party or contemplated by any governmental authority[30](index=30&type=chunk) [3. Revenue from Contracts with Customers](index=9&type=section&id=3.%20Revenue%20from%20Contracts%20with%20Customers) Details revenue recognition policies and disaggregates net sales by product category and geography - Revenue is recognized from sales of two main product categories: (a) **first aid and medical**; and (b) **cutting, sharpening and measuring**[31](index=31&type=chunk) - Revenue is generally recognized at a point in time, with **shipment or delivery**, depending on contract terms[32](index=32&type=chunk) Net Sales by Product Category and Segment (in thousands) | Net Sales by Product Category and Segment | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | **Cutting, Sharpening and Measuring** | | | | United States | $15,333 | $15,564 | | Canada | 1,593 | 1,549 | | Europe | 3,558 | 3,743 | | Total | $20,484 | $20,856 | | **First Aid and Medical** | | | | United States | 20,408 | 20,484 | | Canada | 2,022 | 1,784 | | Europe | 419 | 401 | | Total | $22,849 | $22,669 | | **Total Net Sales** | $43,333 | $43,525 | [4. Debt and Shareholders' Equity](index=10&type=section&id=4.%20Debt%20and%20Shareholders'%20Equity) Outlines the composition of long-term debt, key credit facilities, and compliance with loan covenants - Long-term debt includes borrowings under a revolving loan agreement with HSBC Bank, N.A. (up to **$50 million**, expiring May 24, 2023) and a fixed-rate mortgage (**3.8% interest**, maturing December 1, 2031)[39](index=39&type=chunk)[40](index=40&type=chunk) - The Company was in **compliance with all covenants** under the revolving loan agreement as of March 31, 2022[39](index=39&type=chunk) Debt (in thousands) | Debt | March 31, 2022 | December 31, 2021 | | :--- | :--- | :--- | | Revolving loan outstanding | $40,151 | $33,037 | | Mortgage Payable - HSBC Bank N.A. | 11,522 | 11,620 | | Long-term mortgage payable less current maturities | 10,989 | 11,081 | [5. Segment Information](index=12&type=section&id=5.%20Segment%20Information) Presents financial performance data for the company's three reportable geographic segments - The Company's reportable business segments are **United States** (including aggregated Asian operations), **Canada**, and **Europe**[43](index=43&type=chunk) Financial Data by Segment (in thousands) | Financial Data by Segment | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | **Sales to external customers:** | | | | United States | $35,741 | $36,048 | | Canada | 3,615 | 3,333 | | Europe | 3,977 | 4,144 | | Consolidated | $43,333 | $43,525 | | **Operating income:** | | | | United States | $811 | $2,133 | | Canada | 386 | 370 | | Europe | 174 | 465 | | Consolidated | $1,371 | $2,968 | Assets by Segment (in thousands) | Assets by Segment | March 31, 2022 | December 31, 2021 | | :--- | :--- | :--- | | United States | $134,291 | $125,521 | | Canada | 9,327 | 9,100 | | Europe | 9,459 | 9,818 | | Consolidated | $153,077 | $144,439 | [6. Stock Based Compensation](index=14&type=section&id=6.%20Stock%20Based%20Compensation) Discloses stock-based compensation expenses and unrecognized costs related to non-vested awards - As of March 31, 2022, there was **$3,600,603 of unrecognized compensation cost** related to non-vested share-based payments, expected to be recognized over approximately three years[50](index=50&type=chunk) Stock Compensation Expense (in thousands) | Stock Compensation Expense | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | Stock compensation expense | $400 | $306 | [7. Fair Value Measurements](index=14&type=section&id=7.%20Fair%20Value%20Measurements) The carrying value of the company's bank debt is considered a reasonable estimate of its fair value - The carrying value of the Company's bank debt is a **reasonable estimate of fair value** due to its payment terms and maturity[51](index=51&type=chunk) [8. Leases](index=14&type=section&id=8.%20Leases) Details the company's operating leases, including costs, cash flows, and key assumptions - The Company has operating leases for office and warehouse space and equipment, with **ROU assets and lease liabilities** recognized at commencement date based on the present value of lease payments[52](index=52&type=chunk)[53](index=53&type=chunk) Lease Information (in thousands) | Lease Information | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | | :--- | :--- | :--- | | Operating lease cost | $311 | $336 | | Operating lease - cash flow | $322 | $294 | | ROU assets obtained in exchange for lease liabilities | $211 | $- | | Weighted-average remaining lease term | 3.0 years | 4.0 years | | Weighted-average discount rate | 5% | 5% | [9. Other Accrued Liabilities](index=16&type=section&id=9.%20Other%20Accrued%20Liabilities) Provides a breakdown of other current accrued liabilities, which decreased during the quarter Other Accrued Liabilities (in thousands) | Other Accrued Liabilities | March 31, 2022 | December 31, 2021 | | :--- | :--- | :--- | | Customer Rebates | $5,274 | $5,414 | | Accrued Compensation | 1,291 | 1,586 | | Dividend Payable | 458 | 458 | | Income Tax Payable | 813 | 564 | | Other | 1,101 | 1,887 | | Total | $8,937 | $9,909 | [Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations](index=17&type=section&id=Item%202%3A%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Provides management's perspective on financial performance, operational results, and liquidity [Forward-Looking Information](index=17&type=section&id=Forward-Looking%20Information) Contains forward-looking statements subject to risks and uncertainties under "safe harbor" provisions - The report contains forward-looking statements made pursuant to the **'safe harbor' provisions** of the Private Securities Litigation Reform Act of 1995[62](index=62&type=chunk)[63](index=63&type=chunk) - Actual results could differ materially due to risks from the **COVID-19 pandemic**, economic conditions, competition, and trade policies[63](index=63&type=chunk)[64](index=64&type=chunk) [Critical Accounting Policies](index=17&type=section&id=Critical%20Accounting%20Policies) Refers to the company's 2021 Annual Report for a discussion of critical accounting policies - Critical accounting policies and estimates are discussed in **Item 7 of the Company's Annual Report on Form 10-K** for the year ended December 31, 2021[66](index=66&type=chunk) [COVID-19 Pandemic and Macroeconomic Related Considerations](index=17&type=section&id=COVID-19%20Pandemic%20and%20Macroeconomic%20Related%20Considerations) Discusses the adverse impact of supply chain disruptions and labor challenges on operations - During Q1 2022, the Company experienced **significant supply chain issues** due to new Omicron outbreaks in China, leading to factory and port shutdowns[68](index=68&type=chunk)[69](index=69&type=chunk) - These disruptions contributed to **increased freight, labor, and product costs**, adversely affecting operating margins[70](index=70&type=chunk) - The Company also faced labor-related challenges, including **hiring difficulties, increased labor costs, and higher employee turnover**[71](index=71&type=chunk) [Results of Operations](index=19&type=section&id=Results%20of%20Operations) Analyzes the company's operational results for Q1 2022 compared to the prior year period - The Company's sales are traditionally stronger in the **second and third quarters** due to the back-to-school market[73](index=73&type=chunk) Metric (in thousands) | Metric | Three Months Ended March 31, 2022 | Three Months Ended March 31, 2021 | Change (YoY) | | :--- | :--- | :--- | :--- | | Consolidated Net Sales | $43,333 | $43,525 | -0.44% | | U.S. Sales | Declined 1% | | | | Canada Net Sales | Increased 8% (U.S. & local currency) | | | | European Net Sales | Decreased 4% (U.S. dollars), Increased 3% (local currency) | | | | Gross Profit | $14,968 (34.5% of net sales) | $15,587 (35.8% of net sales) | -4.09% | | SG&A Expenses | $13,597 (31.4% of net sales) | $12,619 (29.0% of net sales) | +7.75% | | Operating Income | $1,371 | $2,968 | -53.74% | | U.S. Operating Income | Decreased by $1,322 | | | | Canadian Operating Income | Increased by $16 | | | | European Operating Income | Decreased by $291 | | | | Interest Expense, Net | $305 | $221 | +38.01% | | Income Tax Expense | 22% effective tax rate | 23% effective tax rate | -1.00% | [Financial Condition](index=20&type=section&id=Financial%20Condition) Reviews the company's financial condition, focusing on liquidity and capital resources [Liquidity and Capital Resources](index=20&type=section&id=Liquidity%20and%20Capital%20Resources) Working capital and debt increased to support inventory growth amid supply chain disruptions - Working capital increased by approximately **$8.2 million** during Q1 2022 compared to December 31, 2021[78](index=78&type=chunk) - Inventory increased by approximately **$7.2 million**, primarily to anticipate continued growth and mitigate potential supply chain disruptions[78](index=78&type=chunk) - Total debt outstanding under the revolving credit facility increased by approximately **$7.1 million** in Q1 2022, with **$9,849,000 available** for borrowing as of March 31, 2022[81](index=81&type=chunk) - The Company believes cash from operations and available credit will be **sufficient to finance operations** for the next twelve months[82](index=82&type=chunk) Financial Ratios (in thousands) | Financial Ratios | March 31, 2022 | December 31, 2021 | | :--- | :--- | :--- | | Working capital | $83,061 | $74,976 | | Current ratio | 4.89 | 4.70 | | Long term debt to equity ratio | 65.8% | 57.2% | [Item 3: Quantitative and Qualitative Disclosures about Market Risk](index=22&type=section&id=Item%203%3A%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) This section states that market risk disclosures are not applicable for this reporting period - Quantitative and qualitative disclosures about market risk are **not applicable**[84](index=84&type=chunk) [Item 4: Controls and Procedures](index=22&type=section&id=Item%204%3A%20Controls%20and%20Procedures) Management concluded that disclosure controls and internal controls were effective as of March 31, 2022 [(a) Evaluation of Internal Controls and Procedures](index=22&type=section&id=(a)%20Evaluation%20of%20Internal%20Controls%20and%20Procedures) The CEO and CFO concluded that disclosure controls and procedures were effective - The Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were **effective as of March 31, 2022**[84](index=84&type=chunk) [(b) Changes in Internal Control over Financial Reporting](index=22&type=section&id=(b)%20Changes%20in%20Internal%20Control%20over%20Financial%20Reporting) No material changes in internal control over financial reporting occurred during the quarter - There were **no changes** in internal control over financial reporting during the quarter ended March 31, 2022, that materially affected, or are reasonably likely to materially affect, internal control over financial reporting[84](index=84&type=chunk) Part II — OTHER INFORMATION [Item 1: Legal Proceedings](index=23&type=section&id=Item%201%3A%20Legal%20Proceedings) There are no pending material legal proceedings involving the company or governmental authorities - There are **no pending material legal proceedings** to which the registrant is a party, or contemplated by any governmental authority[86](index=86&type=chunk) [Item 1A: Risk Factors](index=23&type=section&id=Item%201A%3A%20Risk%20Factors) Refers readers to the Risk Factors section in the company's 2021 Annual Report on Form 10-K - Risk Factors are set forth in **Part I, Item 1A of the Company's Annual Report on Form 10-K** for the fiscal year ended December 31, 2021[86](index=86&type=chunk) [Item 2: Unregistered Sales of Equity Securities and Use of Proceeds](index=23&type=section&id=Item%202%3A%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) There were no unregistered sales of equity securities or use of proceeds during the period - **None**[86](index=86&type=chunk) [Item 3: Defaults Upon Senior Securities](index=23&type=section&id=Item%203%3A%20Defaults%20Upon%20Senior%20Securities) There were no defaults upon senior securities during the reporting period - **None**[86](index=86&type=chunk) [Item 4: Mine Safety Disclosures](index=23&type=section&id=Item%204%3A%20Mine%20Safety%20Disclosures) This item is not applicable to the company - **Not applicable**[86](index=86&type=chunk) [Item 5: Other Information](index=23&type=section&id=Item%205%3A%20Other%20Information) There is no other information to report in this section - **None**[86](index=86&type=chunk) [Item 6: Exhibits](index=23&type=section&id=Item%206%3A%20Exhibits) Lists the exhibits filed as part of the Form 10-Q, including certifications and XBRL documents Exhibit Number | Exhibit Number | Description | | :--- | :--- | | Exhibit 31.1 | Certification of Walter C. Johnsen pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002 | | Exhibit 31.2 | Certification of Paul G. Driscoll pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 302 of the Sarbanes-Oxley Act of 2002 | | Exhibit 32.1 | Certification of Walter C. Johnsen pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | | Exhibit 32.2 | Certification of Paul G. Driscoll pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | | 101.INS | Inline XBRL Instance Document. | | 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | | 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | | 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | | 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | | 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | | 104 | The cover page for the Company's Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101 | [Signatures](index=24&type=section&id=Signatures) The report was duly signed by the CEO and CFO in accordance with the Securities Exchange Act of 1934 - The report was signed on **May 9, 2022**, by Walter C. Johnsen, Chairman of the Board and Chief Executive Officer, and Paul G. Driscoll, Vice President and Chief Financial Officer[89](index=89&type=chunk)
Acme United(ACU) - 2021 Q1 - Quarterly Report
2021-05-06 16:00
[FORM 10-Q Filing Information](index=1&type=section&id=FORM%2010-Q%20Filing%20Information) This section details ACME UNITED CORPORATION's Form 10-Q filing information, including its filer status and outstanding common stock - ACME UNITED CORPORATION filed a Quarterly Report on Form 10-Q for the period ended March 31, 2021[1](index=1&type=chunk) - The registrant is an **Accelerated Filer** and a **Smaller Reporting Company**[2](index=2&type=chunk) - As of May 4, 2021, the company had **3,483,527 shares** of its **$2.50** par value Common Stock outstanding[2](index=2&type=chunk) [Part I - FINANCIAL INFORMATION](index=3&type=section&id=Part%20I%20-%20FINANCIAL%20INFORMATION) This part presents the unaudited condensed consolidated financial statements and management's discussion and analysis of financial condition and results of operations [Item 1: Financial Statements (Unaudited)](index=3&type=section&id=Item%201%3A%20Financial%20Statements%20(Unaudited)) This section presents the unaudited condensed consolidated financial statements for Acme United Corporation, including balance sheets, statements of operations, comprehensive income, changes in stockholders' equity, and cash flows, along with detailed notes. The statements reflect the company's financial position and performance for the quarter ended March 31, 2021, showing overall growth in sales and net income compared to the prior year, while also detailing accounting policies, debt, segment performance, and the status of the PPP loan [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) This section covers condensed consolidated balance sheets Condensed Consolidated Balance Sheet Highlights | Metric | March 31, 2021 ($k) | December 31, 2020 ($k) | | :--------------------------------------------- | :------------- | :---------------- | | Cash and cash equivalents | $3,857 | $4,167 | | Accounts receivable, net | $31,592 | $27,173 | | Inventories | $49,389 | $50,704 | | Total current assets | $87,315 | $83,685 | | Net property, plant and equipment | $21,138 | $20,239 | | Total assets | $135,314 | $129,868 | | Total current liabilities | $20,673 | $20,201 | | Long-term debt | $40,626 | $38,767 | | Long-term debt - PPP Loan | $3,508 | $3,508 | | Total liabilities | $70,687 | $67,151 | | Total stockholders' equity | $64,627 | $62,717 | [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) This section covers condensed consolidated statements of operations Condensed Consolidated Statements of Operations Highlights (Three months ended March 31) | Metric | 2021 ($k) | 2020 ($k) | YoY Change (k$) | YoY Change (%) | | :--------------------------------------------- | :--- | :--- | :-------------- | :------------- | | Net sales | $43,525 | $35,775 | $7,750 | **21.7%** | | Cost of goods sold | $27,938 | $22,244 | $5,694 | **25.6%** | | Gross profit | $15,587 | $13,531 | $2,056 | **15.2%** | | Selling, general and administrative expenses | $12,619 | $11,521 | $1,098 | **9.5%** | | Operating income | $2,968 | $2,010 | $958 | **47.7%** | | Interest expense, net | $221 | $315 | $(94) | **-29.8%** | | Income before income tax expense | $2,670 | $1,652 | $1,018 | **61.6%** | | Income tax expense | $624 | $375 | $249 | **66.4%** | | Net income | $2,046 | $1,277 | $769 | **60.2%** | | Basic earnings per share | $0.61 | $0.38 | $0.23 | **60.5%** | | Diluted earnings per share | $0.52 | $0.36 | $0.16 | **44.4%** | | Dividends declared per share | $0.13 | $0.12 | $0.01 | **8.3%** | [Condensed Consolidated Statements of Comprehensive Income](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) This section covers condensed consolidated statements of comprehensive income Condensed Consolidated Statements of Comprehensive Income (Three months ended March 31) | Metric | 2021 ($k) | 2020 ($k) | | :---------------------------- | :--- | :--- | | Net income | $2,046 | $1,277 | | Foreign currency translation adjustment | $(188) | $(329) | | Comprehensive income | $1,858 | $948 | [Condensed Consolidated Statement of Changes in Stockholders' Equity](index=7&type=section&id=Condensed%20Consolidated%20Statement%20of%20Changes%20in%20Stockholders'%20Equity) This section covers condensed consolidated statement of changes in stockholders' equity Changes in Stockholders' Equity (Three months ended March 31) | Item | 2021 ($k) | 2020 ($k) | | :---------------------------- | :--- | :--- | | Balances, December 31 | $62,717 | $55,705 | | Net income | $2,046 | $1,277 | | Other comprehensive loss | $(188) | $(329) | | Stock compensation expense | $306 | $243 | | Distributions to shareholders | $(436) | $(401) | | Issuance of common stock | $182 | - | | Purchase of treasury stock | - | $(214) | | Balances, March 31 | $64,627 | $55,824 | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) This section covers condensed consolidated statements of cash flows Condensed Consolidated Statements of Cash Flows (Three months ended March 31) | Cash Flow Activity | 2021 ($k) | 2020 ($k) | | :--------------------------------------------- | :--- | :--- | | Net cash (used in) provided by operating activities | $(336) | $793 | | Net cash used in investing activities | $(1,480) | $(2,671) | | Net cash provided by (used in) financing activities | $1,538 | $(526) | | Effect of exchange rate changes on cash and cash equivalents | $(32) | $(146) | | Net change in cash and cash equivalents | $(310) | $(2,550) | | Cash and cash equivalents at beginning of period | $4,167 | $6,822 | | Cash and cash equivalents at end of period | $3,857 | $4,272 | | Cash paid for income taxes | $45 | $319 | | Cash paid for interest | $218 | $340 | [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) This section covers notes to condensed consolidated financial statements [1. Basis of Presentation](index=9&type=section&id=1.%20Basis%20of%20Presentation) This section covers basis of presentation - The accompanying condensed consolidated financial statements are unaudited and include all necessary normal, recurring adjustments[26](index=26&type=chunk) - The adoption of ASU No. 2019-12 (Income Taxes) and ASU No. 2017-04 (Goodwill Impairment) did not have a material effect on the Company's consolidated financial statements[28](index=28&type=chunk)[29](index=29&type=chunk) [2. Commitment and Contingencies](index=9&type=section&id=2.%20Commitment%20and%20Contingencies) This section covers commitment and contingencies - There are no pending material legal proceedings or contemplated governmental authority actions against the Company[30](index=30&type=chunk) [3. Revenue from Contracts with Customers](index=9&type=section&id=3.%20Revenue%20from%20Contracts%20with%20Customers) This section covers revenue from contracts with customers - Revenue is recognized from sales of products grouped into two main categories: (i) cutting, sharpening and measuring; and (ii) first aid and safety[31](index=31&type=chunk) - Revenue is recognized when performance obligations are satisfied, typically at shipment or delivery, with consideration for customer rebates, promotional allowances, and freight allowance programs[32](index=32&type=chunk)[33](index=33&type=chunk) External Net Sales Disaggregated by Product Category and Segment (Three months ended March 31) | Category / Segment | 2021 ($k) | 2020 ($k) | YoY Change (k$) | YoY Change (%) | | :--------------------------------------------- | :--- | :--- | :-------------- | :------------- | | **Cutting, Sharpening and Measuring** | | | | | | United States | $15,564 | $11,728 | $3,836 | **32.7%** | | Canada | $1,549 | $1,422 | $127 | **8.9%** | | Europe | $3,743 | $2,598 | $1,145 | **44.1%** | | **First Aid and Safety** | | | | | | United States | $20,484 | $18,715 | $1,769 | **9.4%** | | Canada | $1,784 | $1,000 | $784 | **78.4%** | | Europe | $401 | $312 | $89 | **28.5%** | | **Total Net Sales** | **$43,525** | **$35,775** | **$7,750** | **21.7%** | [4. Debt and Shareholders' Equity](index=11&type=section&id=4.%20Debt%20and%20Shareholders'%20Equity) This section covers debt and shareholders' equity - Long-term debt primarily consists of borrowings under a **$50 million** revolving loan agreement with HSBC Bank, N.A. (expiring May 24, 2023) and a variable rate mortgage for the Vancouver, WA facility[42](index=42&type=chunk)[43](index=43&type=chunk) - The Company was in compliance with all loan covenants as of March 31, 2021[42](index=42&type=chunk) Debt Outstanding | Debt Type | March 31, 2021 ($k) | December 31, 2020 ($k) | | :--------------------------------------------- | :------------- | :---------------- | | Long-term debt (revolving loan) | $40,626 | $38,767 | | Long-term debt - PPP Loan | $3,508 | $3,508 | | Mortgage payable, net of current portion | $2,844 | $2,911 | [5. Segment Information](index=13&type=section&id=5.%20Segment%20Information) This section covers segment information - The Company operates in three reportable business segments: United States (including Asian operations), Canada, and Europe[44](index=44&type=chunk) - Direct import sales (Asia to U.S. retailers) represented approximately **7%** of total net sales for Q1 2021, up from **6%** in Q1 2020[45](index=45&type=chunk) Sales to External Customers by Segment (Three months ended March 31) | Segment | 2021 ($k) | 2020 ($k) | YoY Change (k$) | YoY Change (%) | | :---------------------------- | :--- | :--- | :-------------- | :------------- | | United States | $36,048 | $30,443 | $5,605 | **18.4%** | | Canada | $3,333 | $2,422 | $911 | **37.6%** | | Europe | $4,144 | $2,910 | $1,234 | **42.4%** | | **Consolidated** | **$43,525** | **$35,775** | **$7,750** | **21.7%** | Operating Income by Segment (Three months ended March 31) | Segment | 2021 ($k) | 2020 ($k) | YoY Change (k$) | YoY Change (%) | | :---------------------------- | :--- | :--- | :-------------- | :------------- | | United States | $2,133 | $1,571 | $562 | **35.8%** | | Canada | $370 | $205 | $165 | **80.5%** | | Europe | $465 | $234 | $231 | **98.7%** | | **Consolidated** | **$2,968** | **$2,010** | **$958** | **47.7%** | Assets by Segment | Segment | March 31, 2021 ($k) | December 31, 2020 ($k) | | :---------------------------- | :------------- | :---------------- | | United States | $118,158 | $113,831 | | Canada | $8,340 | $7,432 | | Europe | $8,816 | $8,605 | | **Consolidated** | **$135,314** | **$129,868** | [6. Stock Based Compensation](index=14&type=section&id=6.%20Stock%20Based%20Compensation) This section covers stock based compensation - Share-based compensation expense was **$306,385** for Q1 2021, up from **$243,000** for Q1 2020[49](index=49&type=chunk) - As of March 31, 2021, **$1,974,640** of unrecognized compensation cost remains, expected to be recognized over approximately **three years**[49](index=49&type=chunk) [7. Fair Value Measurements](index=14&type=section&id=7.%20Fair%20Value%20Measurements) This section covers fair value measurements - The carrying value of the Company's bank debt is a reasonable estimate of fair value due to its payment terms and maturity[50](index=50&type=chunk) [8. Leases](index=14&type=section&id=8.%20Leases) This section covers leases - The Company has operating leases for office and warehouse space and equipment, with terms expiring through 2026[51](index=51&type=chunk) Lease Information | Metric | March 31, 2021 ($k) | March 31, 2020 ($k) | | :---------------------------- | :------------- | :------------- | | Operating lease cost | $336 | $307 | | Operating lease - cash flow | $294 | $271 | | Weighted-average remaining lease term | **4.0 years** | **4.0 years** | | Weighted-average discount rate | **5%** | **5%** | [9. Paycheck Protection Program Loan](index=16&type=section&id=9.%20Paycheck%20Protection%20Program%20Loan) This section covers paycheck protection program loan - The Company received a **$3,508,047** PPP Loan on May 7, 2020, maturing on May 8, 2022, with a **1.00%** interest rate[57](index=57&type=chunk) - An application for forgiveness of the entire PPP loan was submitted in August 2020 and is currently pending SBA approval[59](index=59&type=chunk) - No assurance can be given that the Company's application for loan forgiveness will be approved by the SBA, in whole or in part[59](index=59&type=chunk) [10. Other Accrued Liabilities](index=16&type=section&id=10.%20Other%20Accrued%20Liabilities) This section covers other accrued liabilities Other Accrued Liabilities | Category | March 31, 2021 ($k) | December 31, 2020 ($k) | | :---------------------------- | :------------- | :---------------- | | Customer Rebates | $5,526 | $6,068 | | Accrued Compensation | $1,608 | $3,072 | | Dividend Payable | $436 | $435 | | Income Tax Payable | $1,035 | $460 | | Other | $2,718 | $1,425 | | **Total** | **$11,323** | **$11,460** | [Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations](index=17&type=section&id=Item%202%3A%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on the Company's financial condition and results of operations, highlighting the impact of the COVID-19 pandemic on sales and costs, and detailing the performance across segments. It also discusses liquidity, capital resources, and ongoing efforts to manage operational challenges and supply chain disruptions [Forward-Looking Information](index=17&type=section&id=Forward-Looking%20Information) This section covers forward-looking information - Forward-looking statements are subject to risks and uncertainties, including the ongoing impact of the global COVID-19 pandemic on business, operations, and financial results[66](index=66&type=chunk) - Key risks include the duration and severity of COVID-19, economic downturns, supply chain disruptions, changes in client needs and consumer spending habits, competition, and technological changes[66](index=66&type=chunk)[67](index=67&type=chunk) [Critical Accounting Policies](index=17&type=section&id=Critical%20Accounting%20Policies) This section covers critical accounting policies - Critical accounting policies and estimates are discussed in Item 7 of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020[69](index=69&type=chunk) [COVID-19 Pandemic Related Considerations](index=17&type=section&id=COVID-19%20Pandemic%20Related%20Considerations) This section covers COVID-19 pandemic related considerations - The COVID-19 pandemic has caused weakness in sales of Westcott office and school supplies due to closures, while Westcott craft products gained market share and first aid/safety products saw strong demand[70](index=70&type=chunk)[74](index=74&type=chunk) - The Company incurred increased costs for product acquisition, additional inventory, labor, and facility cleaning, and maintained elevated reserves for outstanding receivables due to credit risks[73](index=73&type=chunk) - Increased short-term manufacturing and sourcing capacity for first aid and safety products and other key components to minimize supply chain disruptions[74](index=74&type=chunk) [Results of Operations](index=19&type=section&id=Results%20of%20Operations) This section covers results of operations - Consolidated net sales for Q1 2021 increased **22%** to **$43,525,000** compared to **$35,775,000** in Q1 2020[75](index=75&type=chunk) - U.S. sales increased **18%** due to growth in Westcott cutting tools and strong first aid/safety product sales - Canadian net sales increased **38%** (**31%** in local currency) primarily due to higher First Aid Central e-commerce sales - European net sales increased **42%** (**31%** in local currency) due to e-commerce growth across all product lines and DMT sharpening products[75](index=75&type=chunk)[76](index=76&type=chunk) - Gross profit percentage decreased to **35.8%** in Q1 2021 from **37.8%** in Q1 2020, mainly due to product mix and higher ocean freight costs[78](index=78&type=chunk) - Operating income increased to **$2,968,000** in Q1 2021 from **$2,010,000** in Q1 2020, with all segments showing growth[80](index=80&type=chunk) - Interest expense, net, decreased by **$94,000** due to a lower average interest rate, partially offset by higher average debt outstanding[80](index=80&type=chunk) [Financial Condition (Liquidity and Capital Resources)](index=20&type=section&id=Financial%20Condition%20(Liquidity%20and%20Capital%20Resources)) This section covers financial condition (liquidity and capital resources) - Working capital increased approximately **$3.0 million** during Q1 2021 compared to December 31, 2020[82](index=82&type=chunk) Key Financial Ratios | Metric | March 31, 2021 | December 31, 2020 | | :---------------------------- | :------------- | :---------------- | | Working capital | $66,642k | $63,484k | | Current ratio | **4.22** | **4.14** | | Long term debt to equity ratio | **72.7%** | **72.0%** | - Total debt outstanding under the revolving credit facility increased by approximately **$1.8 million** in Q1 2021, with **$40,626,000** outstanding and **$9,374,000** available for borrowing[85](index=85&type=chunk) - The Company believes that cash generated from operating activities, combined with available funds under its revolving credit facility, will be sufficient to finance operations for the next **twelve months**[93](index=93&type=chunk) [Item 3: Quantitative and Qualitative Disclosures about Market Risk](index=24&type=section&id=Item%203%3A%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) This section states that there are no material quantitative or qualitative disclosures about market risk applicable for this report - This item is marked as 'Not applicable', indicating no material quantitative or qualitative disclosures about market risk are being provided[95](index=95&type=chunk) [Item 4: Controls and Procedures](index=24&type=section&id=Item%204%3A%20Controls%20and%20Procedures) This section addresses the effectiveness of the Company's disclosure controls and procedures, identifying a material weakness related to inventory controls at a warehouse. It also outlines the remediation efforts underway to address this weakness, with expected completion by the end of 2021 [Evaluation of Internal Controls and Procedures](index=24&type=section&id=Evaluation%20of%20Internal%20Controls%20and%20Procedures) This section covers evaluation of internal controls and procedures - Disclosure controls and procedures were not effective as of March 31, 2021, due to a material weakness related to the inventory cycle count program at the Rocky Mount, NC warehouse[95](index=95&type=chunk) - The identified material weakness did not result in any misstatement of the Company's consolidated financial statements[96](index=96&type=chunk) [Changes in Internal Control over Financial Reporting](index=24&type=section&id=Changes%20in%20Internal%20Control%20over%20Financial%20Reporting) This section covers changes in internal control over financial reporting - The Company is evaluating and changing processes, procedures, and controls related to the Warehouse cycle count program - A new inventory management system is being implemented at the Warehouse, expected by the end of Q2 2021, to improve cycle count efficiency and effectiveness - Additional personnel resources are being allocated to the inventory cycle count program[96](index=96&type=chunk)[97](index=97&type=chunk) - Remediation of the material weakness is expected to be completed as of December 31, 2021[98](index=98&type=chunk) [Part II - OTHER INFORMATION](index=25&type=section&id=Part%20II%20-%20OTHER%20INFORMATION) This part provides other required information, including legal proceedings, risk factors, and exhibits [Item 1 — Legal Proceedings](index=25&type=section&id=Item%201%20%E2%80%94%20Legal%20Proceedings) This section confirms the absence of pending material legal proceedings or governmental actions against the Company - There are no pending material legal proceedings or contemplated governmental authority actions against the Company[100](index=100&type=chunk) [Item 1A — Risk Factors](index=25&type=section&id=Item%201A%20%E2%80%94%20Risk%20Factors) This section refers readers to the comprehensive discussion of risk factors in the Company's Annual Report on Form 10-K - Risk Factors are set forth in Part I, Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019[100](index=100&type=chunk) [Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds](index=25&type=section&id=Item%202%20%E2%80%94%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section covers unregistered sales of equity securities and use of proceeds - No unregistered sales of equity securities and use of proceeds to report[100](index=100&type=chunk) [Item 3 — Defaults Upon Senior Securities](index=25&type=section&id=Item%203%20%E2%80%94%20Defaults%20Upon%20Senior%20Securities) This section covers defaults upon senior securities - No defaults upon senior securities to report[100](index=100&type=chunk) [Item 4 — Mine Safety Disclosures](index=25&type=section&id=Item%204%20%E2%80%94%20Mine%20Safety%20Disclosures) This section covers mine safety disclosures - Mine Safety Disclosures are not applicable[100](index=100&type=chunk) [Item 5 — Other Information](index=25&type=section&id=Item%205%20%E2%80%94%20Other%20Information) This section covers other information - No other information to report[100](index=100&type=chunk) [Item 6 — Exhibits](index=25&type=section&id=Item%206%20%E2%80%94%20Exhibits) This section lists the documents filed as exhibits to the Form 10-Q, including certifications and XBRL documents - Exhibits include certifications under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, and Inline XBRL documents[101](index=101&type=chunk) [Signatures](index=26&type=section&id=Signatures) This section contains the signatures of authorized officers certifying the report on behalf of Acme United Corporation - The report was signed by Walter C. Johnsen, Chairman of the Board and Chief Executive Officer, and Paul G. Driscoll, Vice President and Chief Financial Officer, on May 7, 2021[103](index=103&type=chunk)